USPTO serial 79452462
BUILDING NEW THERAPIES ATOM BY ATOM
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- TMO LAW OFFICE 121
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with BUILDING NEW THERAPIES ATOM BY ATOM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Chemical preparations for medical use, particularly for the diagnosis of cancerous tumors; chemical preparations for medical use for the treatment of cancerous tumors; chemical preparations for medical use for the diagnosis and treatment of tumors using radiotherapy and immunotherapy; chemical preparations comprising nanoparticles for medical use for the diagnosis and treatment of cancerous tumors using radiotherapy; pharmaceutical preparations comprising nanoparticles for the treatment of malignant tumors; radiosensitizing agents for medical use; pharmaceutical compositions for the amplification of radiotherapy; pharmaceutical preparations for the targeted delivery of active ingredients; contrast agents for medical use; products for medical use especially for metabolic pathways; preparation for medical use especially for modifying the bioavailability of therapeutic agents; preparations for medical use especially for modifying liver functions; preparation for medical use for modifying the functions of the reticuloendothelial system; preparation based on nanomaterials for the delivery of therapeutic agents; products for medical use especially for the treatment of brain diseases and disorders; preparation for the diagnosis and treatment of brain diseases and disorders; preparation for medical use particularly for the treatment of Parkinson's disease, Alzheimer's disease, epilepsy and all types of neurological and neuropsychiatric diseases and disorders; preparation for medical use, in particular for treating the symptoms of Parkinson's disease, symptoms of Alzheimer's disease, symptoms of epilepsy and symptoms related to any type of neurological and neuropsychiatric disorders and diseases; preparation for the diagnosis and treatment of neurological disorders and diseases using deep brain stimulation, electrical transcranial stimulation, transcranial direct-current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation (light, magnetic field, electric field), radio frequency or ultrasound stimulation; nanoparticles for medical use; chemical reagents for medical use; biological preparations for medical use; enzymes for medical use; chemical preparations for medical or pharmaceutical use; diagnostic products for medical use; drugs for medical use; medicines for human purposes; tonics (medicines); pharmaceutical products. | ACTIVE | — |
| 010 | Medical devices for the diagnosis and treatment of tumors using radiotherapy and immunotherapy; medical devices using nanoparticles for therapeutic or diagnostic purposes; medical devices for the targeted administration of anti-cancer treatments; medical devices for amplifying or optimizing radiotherapy; medical instruments for delivering or activating therapeutic substances; medical devices for combined diagnosis and therapy; medical devices for the diagnosis and treatment of brain diseases and disorders; surgical and medical devices and instruments for deep brain stimulation, electrical transcranial stimulation, transcranial direct-current stimulation, transcranial magnetic stimulation, any form of electromagnetic stimulation (light, magnetic field, electric field), radio frequency or ultrasound stimulation; apparatus for the recording of electrical brain activity (electrodes, electroencephalograph, micro-electrode arrays); apparatus for neuronal modeling. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 8, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 8, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 4, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 21, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 24, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 24, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 18, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |